In this compelling episode of NLA Industry Innovations, guest host Kevin Maki, PhD, CLS, MNLA sits down with renowned lipidologist and clinical researcher Michael H. Davidson, MD, FACC, MNLA to explore the complex world of pharmaceutical development. Together, they unpack the science behind medical therapies—from early-stage innovation to clinical trials—and dive into the strategic decisions that shape which treatments make it to market.
Dr. Davidson offers a behind-the-scenes look at how pharmaceutical companies weigh scientific promise, regulatory pathways, market dynamics, and patient needs when developing new therapies. The conversation also touches on the challenges of balancing innovation with accessibility, and why some promising treatments never reach the shelves.
Whether you’re a clinician, researcher, or industry insider, this episode provides valuable insights into the forces driving therapeutic advancement in lipidology and beyond.
Sponsored by NewAmsterdam Pharma
Read the publication HERE.
